Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Paradigm Biocapital Advisors LP
Form 13F · Q2 2026

Paradigm Biocapital Advisors LP

CIK 1855655申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$53.4亿
申報組合市值
28
持倉數量
12
Quarters on record
Top 50
持倉數量

Paradigm Biocapital Advisors LP——持倉

共 28 個持倉中的前 28 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1RVMD Revolution Medicines Inc6.4M−4.4%$11.9亿22.3%
2NUVALENT INC Nuvalent Inc5.9M+11.3%$7.3亿13.7%
3EWTX Edgewise Therapeutics Inc10.2M+38.7%$4.2亿7.8%
4GMAB Genmab A/S13.1M+64.8%$3.6亿6.8%
5SYRE Spyre Therapeutics Inc3.8M+96.2%$3.4亿6.4%
6APOGEE THERAPEUTICS INC Apogee Therapeutics Inc1.6M+16.9%$2.1亿3.9%
7ORKA Oruka Therapeutics Inc2.1M−7.6%$2.0亿3.8%
8TNGX Tango Therapeutics Inc6.4M+58.6%$2.0亿3.7%
9BLTE Belite Bio Inc1.2M+10.6%$1.9亿3.6%
10ERAS Erasca Inc9.6M−8.1%$1.7亿3.3%
11TARS Tarsus Pharmaceuticals Inc2.8M+8.3%$1.7亿3.3%
12ALNY Alnylam Pharmaceuticals Inc480,000—$1.4亿2.7%
13INSM Insmed Inc1.3M+5.7%$1.4亿2.6%
14MBX Mbx Biosciences Inc2.5M—$1.4亿2.6%
15PCVX Vaxcyte Inc2.1M−55.6%$1.2亿2.3%
16VRDN Viridian Therapeutics Inc6.7M+113.5%$1.2亿2.3%
17OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc8.7M+8.1%$1.1亿2.0%
18JBIO Jade Biosciences Inc2.9M—$6349万1.2%
19TYRA Tyra Biosciences Inc1.8M−11.0%$5841万1.1%
20ASMB Assembly Biosciences Inc1.6M+133.6%$4270万0.8%
21EYPT Eyepoint Inc2.9M−8.0%$4133万0.8%
22QUIT Achieve Life Science Inc5.0M—$3234万0.6%
23VOR Vor Biopharma Inc1.8M+0.0%$3222万0.6%
24MPLT Maplight Therapeutics Inc685,852—$2458万0.5%
25KARD Kardigan Inc900,000—$2146万0.4%
26LXEO Lexeo Therapeutics Inc4.2M−32.5%$1944万0.4%
27EDIT Editas Medicine Inc5.6M—$1810万0.3%
28IVA Inventiva Sa4.0M+0.0%$1512万0.3%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。